|1.||Morgan, B Paul: 3 articles (11/2015 - 10/2002)|
|2.||Harris, Claire L: 3 articles (11/2015 - 10/2002)|
|3.||Ramaglia, Valeria: 1 article (11/2015)|
|4.||Ruseva, Marieta M: 1 article (11/2015)|
|5.||Wong, Edwin K S: 1 article (02/2015)|
|6.||Kavanagh, David: 1 article (02/2015)|
|7.||Xu, Xi-Lin: 1 article (05/2014)|
|8.||Hu, Ting: 1 article (05/2014)|
|9.||He, Xiao-Wei: 1 article (05/2014)|
|10.||Jiang, Jian-Guo: 1 article (05/2014)|
|1.||Wounds and Injuries (Trauma)
06/01/1997 - "This study investigated investigated the role of the complement cascade in the development of acid aspiration-induced local lung and remote organ injuries using K-76 COONa (K76), an anticomplement agent that inhibits the complement pathway at the C5 step, and its usefulness as a treatment drug. "
07/15/2009 - "Local anticomplement therapy may therefore protect from peritoneal damage during fungal infection of the peritoneum."
05/01/2002 - "[Characterization of antilysozyme and anticomplement signs in brucellae during experimental infection]."
11/01/2001 - "With samples from 66 children, the Epstein-Barr virus status and the infection phase were defined by indirect immunofluorescence and anticomplement fluorescence assays: 11 children were seronegative, 8 had a primary infection, 20 had a recent primary or past infection, and in 27 a reactivated Epstein-Barr virus infection was diagnosed. "
11/01/1986 - "On the other hand, none of 14 patients with herpes simplex virus (HSV) infection and 51 healthy adults showed anticomplement immunofluorescence antibody titres of greater than or equal to 1/10. "
09/01/1973 - "A comparison of indirect, direct inhibition and labelled anticomplement fluorescent antibody tests in the detection of Babesia argentina infection in cattle."
08/30/1974 - "[Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. "
12/15/1987 - "However, neither EBNA nor EBV DNA could be detected in tumor tissue by anticomplement immunofluorescence or in situ cytohybridization with an EBV DNA probe. "
04/01/1977 - "CMV-related intracellular and membrane antigens were detected by indirect and anticomplement immunofluorescence techniques in cells cultured in vitro from the tumors."
01/01/1986 - "Lymph nodes or tumor biopsies of 60 persons suspected of having a malignant lymphoma were examined for the presence of Epstein-Barr virus nuclear antigen (EBNA) by anticomplement immunofluorescence. "
04/01/1978 - "In more than 80% of tumor cells in the pericardiac effusion of a case of malignant B-cell lymphoma, Epstein-Barr virus-determined nuclear antigen (EBNA) was detected by the anticomplement immunofluorescence test. "
|5.||Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/01/2013 - "Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies."
02/01/2015 - "Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome."
01/01/2014 - "Eculizumab, the first available anticomplement therapy, blocks at the level of C5 and has revolutionized the treatment of complement-mediated diseases such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. "
12/01/2008 - "Specifically, we will discuss the role of anticomplement therapy in paroxysmal nocturnal hemoglobinuria, glomerulonephritis, and heart disease, including coronary artery disease, myocardial infarction, and coronary revascularization procedures such as percutaneous coronary angioplasty and coronary artery bypass graft surgery."
|1.||Complement System Proteins (Complement)
|2.||K 76 carboxylic acid
|3.||2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)
|6.||DNA (Deoxyribonucleic Acid)
|7.||Nuclear Antigens (Extractable Nuclear Antigens)
|9.||RNA (Ribonucleic Acid)
|10.||Immunoglobulin M (IgM)
|2.||Angioplasty (Angioplasty, Transluminal)
|3.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)